Sponsor:
Duke University
Code:
NCT07158814
Conditions
Fever
Adverse Event Following Immunisation
Eligibility Criteria
Sex: All
Age: 0
Healthy Volunteers: Accepted
Interventions
Respiratory Syncytial Virus (RSV) Preventive Monoclonal Antibody
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-10-20. This information was provided to ClinicalTrials.gov by Duke University on 2025-10-15.